Zobrazeno 1 - 10
of 16
pro vyhledávání: '"O V Absalyamova"'
Publikováno v:
Современная онкология, Vol 14, Iss 2, Pp 31-37 (2012)
Externí odkaz:
https://doaj.org/article/bad9eaee509847f7948005f9ffd36ad4
Publikováno v:
Современная онкология, Vol 6, Iss 4, Pp 155-157 (2004)
В химиотерапию колоректального рака в последние годы вошел ряд новых активных препаратов, таких как оксалиплатин, томудекс, иринотекан,
Externí odkaz:
https://doaj.org/article/ecb1338bf88640e484b6aaac5696f5b0
Autor:
O V Absalyamova
Publikováno v:
Современная онкология, Vol 15, Iss 1, Pp 10-11 (2013)
Наиболее распространенной злокачественной глиомой является глиобластома (ГБ). Признанным большинством нейроонкологов стандартом перв
Externí odkaz:
https://doaj.org/article/6fac4f9e728f466497e1609fce8148fe
Autor:
O V Absalyamova
Publikováno v:
Современная онкология, Vol 14, Iss 3, Pp 7-8 (2012)
Externí odkaz:
https://doaj.org/article/90e2c87ace1340b481ebab91b012cd90
Autor:
V V Nazarov, O V Absalyamova, Pavel Kalinin, G L Kobyakov, I. A. Muzyshev, Cherekaev Va, E R Vetlova, Spirin Ds, I V Chernov
Publikováno v:
Voprosy neirokhirurgii imeni N.N. Burdenko. 84:101
Sinonasal malignant tumors are characterized by high histological variability and complexity of the differential diagnosis. Currently, there are classifications of these tumors, which are based on their localization and involvement of various anatomi
Autor:
A I Batalov, P V Nikitin, A D Kravchuk, Yu A Shelygin, Alexander Potapov, O V Absalyamova, S V Shugay, Aldo Spallone, Okhlopkov Va, L N Lyubchenko, G L Kobyakov, A A Abdilatipov, Gavrilov Ag, N E Zakharova, A S Kulikov, S A Goryaynov, M D Aliev
Publikováno v:
Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko. 82(4)
Li-Fraumeni syndrome (LFS) is a clinically and genetically heterogeneous hereditary syndrome with predominantly oncological manifestations, which is associated with mutations in the TP53, MDM2, and CHEK2 genes. The most common variant is a TP53 mutat
Autor:
G. I. Kobyakov, A. V. Smolin, A. Kh. Bekyashev, O. V. Absalyamova, E. A. Kobyakova, A. A. Poddubsky, M. V. Inozemtseva
Publikováno v:
Opuholi Golovy i Šei, Vol 0, Iss 3, Pp 12-21 (2015)
The paper analyzes treatments for glioblastoma. The role of resurgery, reradiotherapy, and antitumor drug therapy in the treatment of recurrent glioblastoma has been studied. Multicenter trials of the use of temozolamide and temozolomide in combinati
Autor:
M. V. Ryzhova, O. G. Zheludkova, L. V. Shishkina, L. A. Nikulina, T. N. Panina, A. G. Melikyan, Yu. V. Kushel, M. A. Krasnova, M. Yu. Zemlyansky, D. A. Moshchev, L. A. Israyelyan, V. N. Shimansky, U. B. Makhmudov, D. V. Sidorkin, V. V. Karnaukhov, G. L. Kobyakov, O. V. Absalyamova
Publikováno v:
Opuholi Golovy i Šei, Vol 0, Iss 3, Pp 69-72 (2015)
Tumor cells can differentiate into more mature forms in undifferentiated or poorly differentiated tumors, such as medulloblastomas with increased nodularity, as well as neuroblastomas. The authors describe 2 cases of neuroblastoma maturation into gan
Publikováno v:
Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko. 80(6)
To describe a procedure and outcomes of comprehensive first-line treatment in glioblastoma patients.We analyzed 107 glioblastoma patients operated on in 2010-2011. Seventy five patients underwent combined chemoradiotherapy (CRT) with simultaneous adm
Autor:
A A Nikolaeva, Andrey Golanov, S M Banov, A A Barinov, E V Khokhlova, D V Starovoytov, E N Igoshina, S V Zolotova, A S Belyashova, O V Absalyamova
Publikováno v:
Voprosy neirokhirurgii imeni N.N. Burdenko. 83:17
OBJECTIVE To study the effect of metabolic characteristics of the tumor determined by 99mTc-MIBI single-photon emission computed tomography (SPECT) and various molecular genetic features on the outcomes of combination treatment of hemispheric gliobla